Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in... (anxiety disorder and manage diabetic per...)

Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study

Date:1/30/2009

anxiety disorder and manage diabetic peripheral neuropathic pain. Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Patients should call their doctor right away if they experience new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.

Cymbalta is not for everyone. Patients should not take Cymbalta if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril(R) (thioridazine) or have uncontrolled glaucoma. Patients should speak with their doctor about any medical conditions they may have, including liver or kidney problems, glaucoma, or diabetes. Patients should tell their doctor about all their medicines, including those for migraine, to avoid a potentially life-threatening condition. Taking Cymbalta with NSAID pain relievers, aspirin, or blood thinners may increase bleeding risk. They also should talk to their doctor about their alcohol consumption. Patients should consult with their doctor before stopping Cymbalta or changing the dose and if they are pregnant or nursing.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include nausea, dry mouth, sleepiness and constipation.

    This is not a complete list of side effects.

    For full Patient Information, visit www.cymbalta.com.

For full Prescribing Information, including Boxed Warning and medication guide, visit http://www.cymbalta.com/.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical pr
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
2. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
3. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
4. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
5. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
6. AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly
7. Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
8. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
9. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
10. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
11. Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

Post Your Comments:

(Date:5/23/2013)... , Engeland, May 23, 2013 ... mannen met lagere urinewegsymptomen geassocieerd met BPH ... Europese dochteronderneming van Astellas Pharma Inc, gebaseerd in ... 4503), kondigde vandaag aan dat het Nederlandse College ter ... VESOMNI in Nederland. De handelsvergunning verleend voor ...

(Date:5/22/2013)... , May 22, 2013 Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that the Company will present at ... 29, 2013 at the Le Parker Meridian hotel, 119 W. ... . The presentation is scheduled to begin at 2:15 ... About Heska Heska Corporation (NASDAQ: HSKA ...

(Date:5/22/2013)... 2013 Attorney Advertising -- Bronstein, Gewirtz & ... of purchasers of the securities of AMAG Pharmaceuticals, ... The investigation focuses on whether the Company and ... On May 22, 2013, Shares of AMAG dropped ... company announced in regulatory filing that it has ...

Breaking Medicine Technology:Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2

[0] Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen [0] Heska Corporation to Present at the Stifel Dental & Veterinary Conference [0] Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.

... that a new market research report is available in ... Drug Delivery System http://www.reportlinker.com/p0337136/Chinese-Markets-for--Drug-Delivery-System.html ... System has grown at a fast pace in the ... and demand will continue to grow. This new study ...

... 9, 2010 Reportlinker.com announces that ... catalogue: Prostate Cancer - Italy Drug ... http://www.reportlinker.com/p0332355/Prostate-Cancer---Italy-Drug-Forecasts-and-Treatment-Analysis-to-2020.html Prostate Cancer - Italy ... SummaryGlobalData,s pharmaceutical report, "Prostate Cancer - Italy Drug ...

Reportlinker Adds Chinese Markets for Drug Delivery System Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

(Date:5/23/2013)... This news release is available in French . ... Montreal researchers have discovered a novel molecular mechanism that ... other diseases of abnormal growth. In the May 23 ... from the University of Montreal explain how they found ... or prevents cells from dividing. , "Cells normally monitor ...

(Date:5/23/2013)... Six innovative research projects have been awarded grants ... the nation's largest private nonprofit funder of Lyme disease medical ... epidemiology of, and treatment and cure for Lyme and ... support the innovative research being conducted by some of ... the field today,” said Harriet Kotsoris, MD, LRA’s Chief ...

(Date:5/23/2013)... CT (PRWEB) May 23, 2013 Applied ... solutions, announced today that it has added support for ... IDE, the eiConsole for Healthcare. In addition to ... such as LLP, FTP, and Web Services, it now ... The Direct Protocol is a specification of the ...

(Date:5/23/2013)... During pregnancy both the health of ... medical treatments, especially medication. In July 2006, a ... prompted the FDA to warn about a potential link ... as persistent pulmonary hypertension and other malformations (i). ... (SSRI) drugs. SSRI antidepressants are widely prescribed to ...

(Date:5/23/2013)... Each month Dwell magazine is filled ... and electric cars. Nowhere in America are these pages more ... car capital. Thankfully this June, Green Car Journal is bringing ... to Dwell on Design 2013 ( http://www.dwellondesign.com ), ... two days of Dwell on Design, June 21-22, attendees and ...

Breaking Medicine News(10 mins):Health News:Scientists discover how rapamycin slows cell growth 2 Health News:Six Investigators Awarded Lyme Research Alliance Grants 2 Health News:Six Investigators Awarded Lyme Research Alliance Grants 3 Health News:Six Investigators Awarded Lyme Research Alliance Grants 4 Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2 Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 2 Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 3 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4 Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5

[0] Scientists discover how rapamycin slows cell growth [0] Six Investigators Awarded Lyme Research Alliance Grants [0] PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release [0] Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects [0] Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013

... ,Time is Brain, SEATTLE, Nov. 14 On ... to activate an advanced telemedicine system,in the emergency rooms ... real-time, 24/7 link between ER physicians and stroke specialists ... Stroke,Program is based. The Swedish TeleStroke Program is ...

... Pa., Nov. 14 Escalon Medical Corp.,(Nasdaq: ESMC ... ended,September 30, 2007. For the first quarter of ... 4% decrease from the $7,168,160, reported in the prior,year ... at the,Company,s Sonomed and Vascular business units, which decreased ...

... Passion for Healthcare, MIAMI, Nov. 14 ... healthcare providers funded by,MTS Health Investors and Oaktree ... E. Burke III to the position of President ... experience to Novis,Pharmaceuticals, with extensive functional expertise in ...

... for November 20, NAPA, Calif., Nov. 14 ... company engaged in the,study of senescense, the science of ... today announced financial results for the,quarter ended September 30, ... $469,000 compared to,$2,027,000 for the same period in the ...

... - Now Families Can Breathe Easier During Cold and ... Nature,s Baby Organics,manufacturers of the finest and purest natural ... Ah-Choo! Chest Rub. Ah-Choo! Chest Rub was,created to bring ... common cold viruses and influenza. "With the unavoidable ...

... NEW YORK, NY November 14, 2007 The ... announced today that they are joining together to create ... of research into drugs and therapies to cure diabetes ... can measure the progress of disease and the effectiveness ...

Cached Medicine News:Health News:Lifesaving TeleStroke Technology Linked to Swedish 2 Health News:Lifesaving TeleStroke Technology Linked to Swedish 3 Health News:Lifesaving TeleStroke Technology Linked to Swedish 4 Health News:Lifesaving TeleStroke Technology Linked to Swedish 5 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 2 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 3 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 4 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 5 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 6 Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 7 Health News:Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO 2 Health News:Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO 3 Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 2 Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 3 Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 2 Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 3

Lifesaving TeleStroke Technology Linked to Swedish Escalon(R) Reports First Quarter Fiscal 2008 Results Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO Senetek PLC Reports Third Quarter 2007 Financial Results Nature's Baby Organics Announces Ah-Choo! Chest Rub JDRF and Lilly partner to fund research to identify beta cell biomarkers

...

The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....

Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....

Hoen periosteal elevators, No.3, blade width 3/4" (20 mm), total length 7 1/2" (191 mm)....

Medicine Products:

Cushing Burr Doro Halo Retractor System Codman Periosteal Elevators Hoen Periosteal Elevators